The DOI matches its Crossref record; 96 of the 97 references it cites were found in a registry or an index.
Prevalence of anxiety among breast cancer patients: a systematic review and meta-analysis
Abstract
This study aimed to determine the prevalence of anxiety among breast cancer patients. In April 2019, three electronic databases (PubMed, Web of Science, and Scopus) were searched from January, 2000 to March, 2019. Key words included were as follows: breast neoplasm, prevalence, and anxiety. A total of 36 studies that included 16,298 breast cancer patients between 2000 and 2018 were enrolled in the study. The prevalence of anxiety among breast cancer patients was 41.9% [(CI: 95%): 30.7, 53.2]. The prevalence of anxiety among patients in Mediterranean countries was higher. The study showed a high level of anxiety among breast cancer patients, indicating the importance of psychological factors as well as physical in breast cancer patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Severe FOP can influence cancer patients' quality of life (QOL) 1 and have significant adverse effect on their healthcare services.1”
From A randomized clinical trial: Efficacy of group-based acceptance and commitment therapy program for breast cancer patients with high fear of progression (2024) · cites this paper as [1]
In the citing paper
“For anxiety, studies using self-report instruments with specified cutoff points (eg, Hospital Anxiety and Depression Scale $ 8) find prevalence estimates between 4% and 48%.36”
From Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023) · cites this paper as [36]
In the citing paper
“clinically significant symptoms of depression and anxiety [5,6]”
From Co-Designing the MOSAIC mHealth App With Breast Cancer Survivors: User-Centered Design Approach (2024) · cites this paper as [6]
In the citing paper
“Meta-analyses report an overall global prevalence of anxiety in BC patients at around 41.9%, with signifcantly higher rates in developing countries like Iran, where it reaches 65.5% [11,12].”
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
Walker, E. R., McGee, R. E., & Druss, B. G. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.2502 · Cited by 2,976
Hoy, D., Brooks, P., Woolf, A., Blyth, F., March, L., Bain, C., Baker, P., Smith, E., & Buchbinder, R. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.11.014 · Cited by 2,555
CA: A Cancer Journal for Clinicians
(2010) · CA A Cancer Journal for Clinicians · doi:10.3322/(issn)1542-4863 · Cited by 2,538
Mitchell, A. J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C., & Meader, N. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70002-x · Cited by 2,449
Global prevalence of anxiety disorders: a systematic review and meta-regression
Baxter, A. J., Scott, K. M., Vos, T., & Whiteford, H. A. (2013) · Psychological Medicine · doi:10.1017/s003329171200147x · Cited by 1,537
Depression and anxiety in women with early breast cancer: five year observational cohort study
Burgess, C., Cornelius, V., Love, S., Graham, J., Richards, M., & Ramirez, A. (2005) · BMJ · doi:10.1136/bmj.38343.670868.d3 · Cited by 1,334
Research works printed but not linked: 3
- World Health Organization. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. Geneva: World Health Organization; 1993.
- Schreier AM, Williams SA, editors. Anxiety and quality of life of women who received radiation or chemotherapy for breast cancer. Oncology nursing forum. Pennsylvania: Oncology Nursing Society; 2004.
- Lueboonthavatchai P. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients. J Med Assoc Thail (Chotmaihet Thangphaet). 2007;90(10):2164–74.
Cited by
Wang, X., Wang, N., Zhong, L., Wang, S., Zheng, Y., Yang, B., Zhang, J., Lin, Y., & Wang, Z. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00865-6 · Cited by 512
Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update
Andersen, B. L., Lacchetti, C., Ashing, K., Berek, J. S., Berman, B. S., Bolte, S., Dizon, D. S., Given, B., Nekhlyudov, L., Pirl, W., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00293 · Cited by 318
“For anxiety, studies using self-report instruments with specified cutoff points (eg, Hospital Anxiety and Depression Scale $ 8) find prevalence estimates between 4% and 48%.(36) In studies using diagnostic interviews, the prevalence is approximately 10%.”
MethodYang, Y., Sun, H., Luo, X., Li, W., Yang, F., Xu, W., Ding, K., Zhou, J., Liu, W., Garg, S., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.04.119 · Cited by 152
Prevalence and determinants of anxiety and depression in long-term breast cancer survivors
Breidenbach, C., Heidkamp, P., Hiltrop, K., Pfaff, H., Enders, A., Ernstmann, N., & Kowalski, C. (2022) · BMC Psychiatry · doi:10.1186/s12888-022-03735-3 · Cited by 153
Sexual Dysfunction in Women with Cancer: A Systematic Review of Longitudinal Studies
Guedes, T. S. R., Guedes, M. B. O. G., Santana, R. D. C., da Silva, J. F. C., Dantas, A. A. G., Ochandorena‐Acha, M., Terradas‐Monllor, M., Jerez‐Roig, J., & de Souza, D. L. B. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191911921 · Cited by 98
“9% of women had anxiety, considered an important risk factor for increasing the illness and suffering of women, partners, and family members [41].”
Background
Metadata
- Authors
- Hashemi, S.-M., Rafiemanesh, H., Aghamohammadi, T., Badakhsh, M., Amirshahi, M., Sari, M., Behnamfar, N., & Roudini, K.
- Affiliations
- Zahedan University of Medical Sciences (IR)
- Shahid Beheshti University (IR)
- University of Neyshabur (IR)
- Zabol University of Medical Sciences (IR)
- Islamic Azad University, Tehran (IR)
- University of Tehran (IR)
- Corresponding author
- Badakhsh, Mahin
- Venue
- Breast Cancer
- Published
- 2019-12-11
- Volume
- 27
- Issue
- 2
- Pages
- 166-178
- ISSN
- 1340-6868 (ISSN-L)
- 1880-4233
- OpenAlex
- W2995059508
- Cited by
- 243
- References
- 97
- Citations by year
- 2026: 24 · 2025: 46 · 2024: 65 · 2023: 47 · 2022: 45 · 2021: 12 · 2020: 4
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Breast Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Keywords
- anxiety, prevalence, psychological factors, Mediterranean countries, cancer patients
- MeSH terms
- Africa, Americas, Anxiety, Breast Neoplasms, Europe, Female, Humans, Middle East, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevalence of anxiety among breast cancer patients: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1007/s12282-019-01031-9
- The paper
- Hashemi, S.-M., Rafiemanesh, H., Aghamohammadi, T., Badakhsh, M., Amirshahi, M., Sari, M., Behnamfar, N., & Roudini, K. (2020). Prevalence of anxiety among breast cancer patients: a systematic review and meta-analysis. Breast Cancer. https://doi.org/10.1007/s12282-019-01031-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.